Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

FDA accepts sNDA for Auryxia

March 9, 2017

FDA approves Noctiva for nocturnal polyuria

March 6, 2017

AURA-LV study of voclosporin in lupus nephritis meets 48-week remission endpoints

March 3, 2017

EMA CHMP gives positive opinion on ZS-9 for hyperkalemia

Feb. 27, 2017

Reata initiates phase II/III study of bardoxolone methyl to treat Alport syndrome-associated CKD

Feb. 24, 2017

Revive Therapeutics and InMed in term sheet agreement for cannabinoid therapies for kidney diseases

Feb. 23, 2017

Lanthio Pharma initiates first-in-human trial of MOR-107

Feb. 22, 2017

Astellas Pharma describes novel MC4 receptor agonists

Feb. 17, 2017

Ardelyx's phase III trial of tenapanor meets primary endpoint

Feb. 15, 2017

Ionis Pharmaceuticals earns milestone from Bayer for advancing antisense drugs

Feb. 15, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...